| Ticker Details |
Novo-Nordisk A/S
Novo Nordisk A/S is a healthcare company. It is engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The company's business segments include, diabetes and obesity care, and biopharmaceuticals.
|
| IPO Date: |
April 1, 1981 |
| Sector: |
Healthcare |
| Industry: |
Pharma |
| Market Cap: |
$216.28B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.78 | 0.98%
|
| Avg Daily Range (30 D): |
$0.74 | 1.65%
|
| Avg Daily Range (90 D): |
$0.72 | 1.74%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
2.64M |
| Avg Daily Volume (30 D): |
11.36M |
| Avg Daily Volume (90 D): |
14.77M |
| Trade Size |
| Avg Trade Size (Sh.): |
144 |
| Avg Trade Size (Sh.) (30 D): |
113 |
| Avg Trade Size (Sh.) (90 D): |
125 |
| Institutional Trades |
| Total Institutional Trades: |
31,452 |
| Avg Institutional Trade: |
$4.1M |
| Avg Institutional Trade (30 D): |
$4.48M |
| Avg Institutional Trade (90 D): |
$3.24M |
| Avg Institutional Trade Volume: |
.11M |
| Avg Institutional Trades (Per Day): |
7 |
| Market Closing Trades |
| Avg Closing Trade: |
$6.92M |
| Avg Closing Trade (30 D): |
$30.85M |
| Avg Closing Trade (90 D): |
$28.74M |
| Avg Closing Volume: |
133.06K |
|
|
| Splits |
|
Sep 20, 2023
|
2:1
|
|
Jan 09, 2014
|
5:1
|
|
Dec 17, 2007
|
2:1
|
|
Apr 11, 2001
|
5:2
|
|
|
|